The Net Margin of Regeneron Pharmaceuticals Inc (REGN) is 31.07%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 31.07% |
| 2023-12-31 | 30.14% |
| 2022-12-31 | 35.64% |
| 2021-12-31 | 50.24% |
| 2020-12-31 | 41.34% |
| 2019-12-31 | 26.91% |
| 2018-12-31 | 36.42% |
| 2017-12-31 | 20.42% |
| 2016-12-31 | 18.44% |
| 2015-12-31 | 15.50% |